Oncostatin M may be a promising drug for treating viral hepatitis and liver cancer
The Department of Gene Therapy and Hepatology of the Center for Applied Medical Research (CIMA) of the University of Navarra has identified a molecule as possibly effective for improving the treatment of chronic hepatitis and liver cancer.
Targeted Nanospheres Find, Penetrate, then Fuel Burning of Melanoma
Hollow gold nanospheres equipped with a targeting peptide find melanoma cells, penetrate them deeply, and then cook the tumor when bathed with near-infrared light, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reported in the Feb. 1 issue of Clinical Cancer Research
Surgeons Use Microwave Technology To Destroy Liver Tumors
A new minimally-invasive option for treating liver tumors, called microwave ablation, is now available at UC San Diego Medical Center and Moores UCSD Cancer Center, the only hospitals in the region to offer this technology to patients.
Highest levels of artificial light at night: the highest rates of prostate cancer
This discovery joins the findings of a previous study by the same researchers that found a connection between exposure to artificial light at night and the incidence of breast cancer.
Two Drugs Kill Resistant Melanoma Cells In Preclinical Study
Combining a well-known biologic agent with a new targeted anticancer drug triggers the death of melanoma cells that are resistant to therapy, according to an animal and laboratory study by Ohio State University Comprehensive Cancer Center researchers.